Main Street Financial Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Main Street Financial Solutions’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-278	Closed	-$292K	–	553
2024 Q3	$292K	Buy	278 +4	+1%	+$4.45K	0.03%	429
2024 Q2	$288K	Buy	274 +1	+0.4%	+$969	0.03%	439
2024 Q1	$263K	Buy	273 +6	+2%	+$5.71K	0.03%	438
2023 Q4	$235K	Sell	267 -2	-0.7%	-$1.65K	0.03%	412
2023 Q3	$221K	Buy	+269	New	+$211K	0.03%	416
2023 Q2	–	Sell	-272	Closed	-$223K	–	455
2023 Q1	$223K	Buy	+272	New	+$205K	0.03%	408
2022 Q2	–	Sell	-293	Closed	-$205K	–	482
2022 Q1	$205K	Buy	+293	New	+$185K	0.03%	426
2021 Q2	–	Sell	-2,781	Closed	-$1.32M	–	453
2021 Q1	$1.32M	Buy	+2,781	New	+$1.35M	0.23%	103

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Main Street Financial Solutions's REGN Position: Q4 2024 in Review

Main Street Financial Solutions sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 278 shares — an estimated $292K sold.

Main Street Financial Solutions first reported a position in REGN in Q1 2021 and held it in 8 quarters. The position peaked at $1.32M in Q1 2021. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

Main Street Financial Solutions reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Main Street Financial Solutions sold 278 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $292K.
Main Street Financial Solutions first reported a position in Regeneron Pharmaceuticals in Q1 2021 and held it in 8 quarters.
Main Street Financial Solutions's Regeneron Pharmaceuticals position peaked at $1.32M in Q1 2021.
1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Main Street Financial Solutions's 13F filing for Q4 2024, filed 13 Feb 2025.